Milestone Pharmaceuticals Inc (MIST) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $1.72
• Market Cap: $147.34M
• EPS: $-0.79
• 52-Week High: $3.06
• 52-Week Low: $0.63

Market Sentiment

Milestone Pharmaceuticals Inc currently has a Neutral sentiment score of -0.01.

About Milestone Pharmaceuticals Inc

Milestone Pharmaceuticals Inc. (MIST) is an innovative biopharmaceutical company based in Montreal, dedicated to developing advanced therapies for cardiovascular conditions. The company's robust pipeline is designed to address significant unmet medical needs, leveraging sophisticated clinical research methodologies to create transformative treatments. Milestone's commitment to enhancing patient outcomes positions it as a vital contender in the healthcare sector, offering institutional investo...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Milestone Pharmaceuticals Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does MIST pay dividends?

Milestone Pharmaceuticals Inc (MIST) does not currently pay a regular dividend.

What is MIST's market cap?

Milestone Pharmaceuticals Inc (MIST) has a market capitalization of $147.34M with a current stock price of $1.72.